Table 2. Virucidal efficacies of Rox500, Pax500, Ron + SL and saturated SL at 1°C.
| Solution type | Virus | Viral titer (log10TCID50/ml) at different contact times | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 sec | 5 sec | 30 sec | 1 min | 3 min | 10 min | 30 min | 60 min | ||
| Rox500a | AIV | 8.91 ± 0.24 | NT | NT | 6.08 ± 0.07 | NT | 4.41 ± 0.37e | 4.16 ± 0.07e | 3.75 ± 0.11e |
| Pax500b | 8.58 ± 0.16 | NT | NT | 6.41 ± 0.13 | NT | 4.67 ± 0.07e | 4.33 ± 0.13e | 3.58 ± 0.07e | |
| Rox500 | NDV | 9.25 ± 0.00 | NT | NT | 7.08 ± 0.07 | NT | 7.00 ± 0.23 | 4.67 ± 0.36e | 4.58 ± 0.49e |
| Pax500 | 9.62 ± 0.15 | NT | NT | 8.00 ± 0.50 | NT | 7.50 ± 0.35 | 4.83 ± 0.36e | 4.25 ± 0.50e | |
| Ron+SL c | AIV | 7.83 ± 0.068 | NT | NT | 6.17 ± 0.29 | 6.08 ± 0.136 | NT | NT | 5.67 ± 0.07 |
| NDV | 9.08 ± 0.068 | NT | 7.50 ± 0.00 | 7.50 ± 0.00 | 7.50 ± 0.00 | NT | NT | 6.33 ± 0.07 | |
| FAdV | 7.07 ± 0.068 | 5.25 ± 0.00 | 3.75 ± 0.71e | NT | NT | NT | NT | NT | |
| ARV | 8.41 ± 0.068 | 5.16 ± 0.07e | 3.83 ± 0.27e | NT | NT | NT | NT | NT | |
| Saturated SLd | AIV | 7.83 ± 0.068 | NT | NT | 7.50 ± 0.00 | NT | 7.50 ± 0.00 | 7.50 ± 0.00 | 7.25 ± 0.07 |
| NDV | 9.08 ± 0.068 | NT | NT | 7.50 ± 0.00 | NT | 7.50 ± 0.00 | 7.50 ± 0.00 | 6.91 ± 0.13 | |
a Quaternary ammonium compounds (QAC) -Rontect® from Scientific Feed Laboratory Co., Ltd. (Tokyo, Japan) was diluted 1:500 with 0.17% FdCa(OH)2. b QAC (Pacoma®), Meiji Seika Pharma Co. (Tokyo, Japan) was diluted 1:500 with 0.17% FdCa(OH)2. c Solid slaked lime 0.24 g and 200 µl QAC-Rontect® added in 100 ml dW2. d Solid slaked lime 0.24 g added in 100 ml dW2. e Effective viral inactivation if ≥3 log10 tissue culture infective dose 50/ml (TCID50/ml). Data represent means ± standard error of 3 different experiments. ‘NT’ denoted as not tested.